trending Market Intelligence /marketintelligence/en/news-insights/trending/8ybmgci1tjmbrhqvsrcbqw2 content esgSubNav
In This List

XBiotech names director

Blog

Insight Weekly: Private equity slows; SPAC underwriters retreat; carbon capture boost

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms


XBiotech names director

XBiotech Inc. elected Donald MacAdam as a board member.

MacAdam is currently a director of Hammond Power Solutions Inc. and has previously served as CEO of MBVax Bioscience Inc.

Austin, Texas-based XBiotech develops antibodies for treating diseases such as cancer, inflammatory conditions and vascular diseases.